The North America arthroscopy devices market is expected to grow from US$ 2,342.20 million in 2021 to US$ 3,963.23 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028.
Musculoskeletal disorders (MSDs) are the most common health conditions across the region. According to the data published by the World Health Organization (WHO), in February 2021, approximately 1.71 billion individuals suffered from musculoskeletal problems. Lower back pain is a widespread musculoskeletal condition, affecting 568 million people. Lower back pain is the major cause of impairment in many countries across the region. Musculoskeletal disorders severely impair mobility and dexterity, resulting in early retirement from work, decreased well-being, and diminished ability to participate in society. The number of people disabled by musculoskeletal conditions has been growing, and this trend is expected to continue in the next decades. Furthermore, as per the WHO, high-income countries are the most affected in terms of population. Musculoskeletal diseases are also the leading cause of years lived with disability (YLDs) across the region. Surgical arthroscopy is a well-established therapy option for individuals with chronic joint pain and dysfunction. Compared to open joint procedures, arthroscopy is less invasive and results in better overall patient outcomes in symptom treatment, hospital stay, structural recovery, and long-term outcomes. Thus, the growing prevalence of musculoskeletal disorders, osteoarthritis, and rheumatoid arthritis is driving the market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America arthroscopy devices market. The North America arthroscopy devices market is expected to grow at a good CAGR during the forecast period.
The North America arthroscopy devices market is segmented based on product, application, and country. Based on product, the market is segmented into arthroscopic implants, arthroscopes, fluid management systems, radiofrequency systems, visualization systems, powered shavers systems, and other arthroscopy instruments. The arthroscopes segment dominated the market in 2020, and the same segment is expected to be the fastest-growing segment during the forecast period. Based on application, the market is segmented into knee arthroscopy, hip arthroscopy, spine arthroscopy, foot and ankle arthroscopy, shoulder and elbow arthroscopy, and others. The hip arthroscopy segment dominated the market in 2020, and the same segment is expected to be the fastest-growing segment during the forecast period. Based on country, the North America arthroscopy devices market has been segmented into the US, Canada, and Mexico.
ARL STORZ SE & Co. KG; Arthrex, Inc.; CONMED Corporation; Johnson and Johnson Services, Inc.; Medtronic; NuVasive, Inc.; Richard Wolf GmbH.; Smith & Nephew; Stryker Corporation; and Zimmer Biomet are among the leading companies in the North America arthroscopy devices market.